MarketResearchReports.com has announced the addition of “Biologics Outsourcing Global Market - Forecast to 2027” research report to their offering. See more at - http://mrr.cm/wge

1. www.MarketResearchReports.com
Category : Biotechnology
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: December 19, 2018
 Number of Pages: 573
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 7,200
Price For Site User License: USD 9,000
Price For Global User License: USD 12,000
Delivery Time: Within 24 Hours (During Working
Days)

3. www.MarketResearchReports.com
About the Report
The biologics outsourcing global market is
expected to grow at double digit CAGR to reach
$87.6 billion by 2027. Biologics are therapeutic
entities composed of sugars, proteins, or nucleic
acids made from natural sources such as human,
animal or micro organisms.
Biologics can also include live attenuated
microorganisms (vaccines), allergenic extracts
(allergy shots), human cells and tissues
(transplantation), cell therapies and gene therapies.

4. www.MarketResearchReports.com
Key Highlights:
Although biologics are much costlier than small
molecule drugs, these classes of drugs prove to be
highly beneficial for the patient and also bring about 40%
higher profits to the manufacturers when compared to
small molecule drug treatments.
Due to the increasing demand for biologics drugs and
increased regulatory approvals for these drugs, there is
huge demand for biologics manufacture and testing at
various levels of clinical studies as well as commercial
supply.
The Large Biopharma companies are coming up with
strategies to cut down on their operational costs and
concentrate more on their core competencies by
outsourcing this piece of work to contract research
organizations (CROs), contract development and
manufacturing organizations (CDMOs) and contract
manufacturing organizations (CMOs).

5. www.MarketResearchReports.com
Key Highlights: Continues..
These organizations bridge the gap between demand
and supply and ensure the drug discovery process gets
much faster and convenient thus bringing life saving
drugs to the market to reach the needy patients.
In 2017, seven out of 10 blockbuster drugs were
biologics outnumbering small molecule drugs. Some of
the top selling biologics in 2017 includes Humira ($18.4
billion), Rituxan ($9.2 billion), Enbrel ($7.9 billion), and
Herceptin ($7.4 billion).
The growth of biologics market indirectly indicates the
huge demand for services spanning all stages of
biologics development starting preclinical stage to
commercial manufacturing.
The high complexity of biologics development and
manufacture requiring huge technical expertise is
prompting major biopharma companies turn to
outsourcing as a viable option.

6. www.MarketResearchReports.com
Key Highlights: Continues..
Preclinical development services- Involves in-vitro and
in-vivo studies of the biologic drug candidates before
testing them on humans to test the safety, efficacy and
biological functionality against the disease target.
Preclinical services include cell line engineering,
process development, product analytical
characterization, cGMP cell banking, cell line
characterization, animal model assay development and
testing services.
Clinical development- Clinical development includes
testing potential drug candidates on humans in phase I,
II and II trials.
Services at this stage include cGMP grade clinical
supply of biologics such as MAb, or recombinant
protein, stability testing, fill/finish and regulatory
support.

7. www.MarketResearchReports.com
Report Coverage:
1. Biologics Outsourcing Global Market
2. Market Analysis
3. Biologics Outsourcing Global Market, Market
Analysis
4. Biologics Outsourcing Global Market – Animal
Model Services
5. Biologics Outsourcing Global Market -
Biomanufacturing
6. Biologics Outsourcing Global Market - Cell Line
Development
7. Company Profiles
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

8. www.MarketResearchReports.com
Company Coverage: (Partial List)
1. Abzena Plc
2. Adimab Llc
3. Albany Molecular Research, Inc
4. Beijing Vital Star Biotechnology Co. Ltd.
5. Boehringer Ingelheim Revenue Overview
6. Catalent Inc.
7. Charles River Laboratories
8. Crown Biosciences
9. Genoway
10. Genscript Biosciences Corporation
11. Gl Biochem
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

9. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter
at:
http://www.marketresearchreports.com/subscribe-to-
newsletter

10. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/wge
About MarketResearchReports.com
Market Research Reports provides a customized set of
reports from reputed Publishers, built on the intelligence
available within organizations and leverages on our
motto of “Intelligence Redefined”.
Contact : Mr. Sudeep Chakravarty
Email : info@marketresearchreports.com
Phone: +1-302-703-9904 (USA) +91-8762746600 (India)